Company intelligence / Profile preview

BizCom

Ownership: Private
Development stage: Other

Overview

BizCom Japan is an active trading and consulting company specializing in sales, marketing, import/export of research reagents, equipment, and services for the life science sector. It provides R&D support to biotech/pharma clients in areas such as antibodies, proteins, nucleic acids (including aptamers), small molecules, cell culture systems, humanized animal models for drug discovery/toxicology studies. The company also arranges licensing deals and collaborations between Japanese clients and international suppliers[1][2][3].

Modalities: AntibodyProteinRNA/DNA (including aptamer)Small molecule
Industry: Consulting

Partnerships

Aptamer Group (distribution of Optimer platform in Japan)

Beyond the preview

Go deeper on BizCom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BizCom.

Explore the full profile